Anyang-si, South Korea

Jei Man Ryu

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Anyang, KR (2015)
  • Anyang-si, KR (2011 - 2017)
  • Gyeonggi-do, KR (2011 - 2020)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Jei Man Ryu in Pharmaceutical Patents**

Introduction

Jei Man Ryu is a distinguished inventor based in Anyang-si, South Korea, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Ryu has dedicated his career to developing innovative compounds and compositions aimed at improving healthcare outcomes.

Latest Patents

Ryu’s latest patents showcase his expertise in creating compounds that have profound effects on medical treatment. One notable invention is a novel compound that inhibits platelet aggregation, alongside its salts, offering a crucial advancement in the treatment of thrombotic diseases. This invention specifically targets shear stress-induced platelet aggregation, presenting new possibilities for pharmaceutical compositions containing this active ingredient. Another significant patent is the R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid with L-aspartic acid salt. This patent emphasizes a more soluble, less toxic antimicrobial agent that exhibits fewer side effects than traditional salts, thus enhancing its viability for both oral and injectable administration.

Career Highlights

Throughout his career, Jei Man Ryu has collaborated with notable companies, including Dong Wha Pharmaceutical Co. Ltd. and Arimed Inc. His work in these organizations has been pivotal in driving forward pharmaceutical innovations that have the potential to make a significant impact on public health.

Collaborations

Jei Man Ryu has worked alongside esteemed colleagues such as Jin Soo Lee and Dong Rack Choi. Their collaborative efforts have contributed to the successful development of innovative pharmaceutical solutions that address critical medical challenges.

Conclusion

In summary, Jei Man Ryu’s extensive portfolio of patents highlights his pivotal role as an inventor in the pharmaceutical industry. His groundbreaking research and innovative compounds not only enhance medical treatments but also signify a promising future for advancements in healthcare. The expertise and collaboration he has exhibited throughout his career continue to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…